Literature DB >> 25619129

Absence of system xc- in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision.

Eduard Bentea1, Thomas Demuyser2, Joeri Van Liefferinge2, Giulia Albertini2, Lauren Deneyer1, Julie Nys3, Ellen Merckx1, Yvette Michotte2, Hideyo Sato4, Lutgarde Arckens3, Ann Massie1, Ilse Smolders5.   

Abstract

There is considerable preclinical and clinical evidence indicating that abnormal changes in glutamatergic signaling underlie the development of mood disorders. Astrocytic glutamate dysfunction, in particular, has been recently linked with the pathogenesis and treatment of mood disorders, including anxiety and depression. System xc- is a glial cystine/glutamate antiporter that is responsible for nonvesicular glutamate release in various regions of the brain. Although system xc- is involved in glutamate signal transduction, its possible role in mediating anxiety or depressive-like behaviors is currently unknown. In the present study, we phenotyped adult and aged system xc- deficient mice in a battery of tests for anxiety and depressive-like behavior (open field, light/dark test, elevated plus maze, novelty suppressed feeding, forced swim test, tail suspension test). Concomitantly, we evaluated the sensorimotor function of system xc- deficient mice, using motor and sensorimotor based tests (rotarod, adhesive removal test, nest building test). Finally, due to the presence and potential functional relevance of system xc- in the eye, we investigated the visual acuity of system xc- deficient mice (optomotor test). Our results indicate that loss of system xc- does not affect motor or sensorimotor function, in either adult or aged mice, in any of the paradigms investigated. Similarly, loss of system xc- does not affect basic visual acuity, in either adult or aged mice. On the other hand, in the open field and light/dark tests, and forced swim and tail suspension tests respectively, we could observe significant anxiolytic and antidepressive-like effects in system xc- deficient mice that in certain cases (light/dark, forced swim) were age-dependent. These findings indicate that, under physiological conditions, nonvesicular glutamate release via system xc- mediates aspects of higher brain function related to anxiety and depression, but does not influence sensorimotor function or spatial vision. As such, modulation of system xc- might constitute the basis of innovative interventions in mood disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Sensorimotor; System xc-; Vision; xCT

Mesh:

Substances:

Year:  2015        PMID: 25619129     DOI: 10.1016/j.pnpbp.2015.01.010

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

Review 1.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

2.  Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.

Authors:  Jingxue Shi; Yan He; Sandra J Hewett; James A Hewett
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

Review 3.  Influence of glutamate and GABA transport on brain excitatory/inhibitory balance.

Authors:  Sheila Ms Sears; Sandra J Hewett
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-07

4.  Chronic Sulfasalazine Treatment in Mice Induces System xc - - Independent Adverse Effects.

Authors:  Lise Verbruggen; Lindsay Sprimont; Eduard Bentea; Pauline Janssen; Azzedine Gharib; Lauren Deneyer; Laura De Pauw; Olaya Lara; Hideyo Sato; Charles Nicaise; Ann Massie
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

5.  Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.

Authors:  Mina G Nashed; Robert G Ungard; Kimberly Young; Natalie J Zacal; Eric P Seidlitz; Jennifer Fazzari; Benicio N Frey; Gurmit Singh
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

6.  Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions.

Authors:  Neil Dawson; Judith A Pratt; Brian J Morris; Emma J Mitchell; David M Thomson; Rebecca L Openshaw; Greg C Bristow
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

7.  Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression.

Authors:  Ipsit Srivastava; Erika Vazquez-Juarez; Lukas Henning; Marta Gómez-Galán; Maria Lindskog
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

Review 8.  Overview of Glutamatergic Dysregulation in Central Pathologies.

Authors:  Tanya Miladinovic; Mina G Nashed; Gurmit Singh
Journal:  Biomolecules       Date:  2015-11-11

Review 9.  Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.

Authors:  Renita M Martis; Luis J Knight; Paul J Donaldson; Julie C Lim
Journal:  Oxid Med Cell Longev       Date:  2020-06-18       Impact factor: 6.543

10.  Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter.

Authors:  Eduard Bentea; Agnès Villers; Cynthia Moore; Adam J Funk; Sinead M O'Donovan; Lise Verbruggen; Olaya Lara; Pauline Janssen; Laura De Pauw; Noemi B Declerck; Erica A K DePasquale; Madeline J Churchill; Hideyo Sato; Emmanuel Hermans; Lutgarde Arckens; Charles K Meshul; Laurence Ris; Robert E McCullumsmith; Ann Massie
Journal:  Mol Psychiatry       Date:  2020-05-04       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.